Clofarabine
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Clofarabine?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Clofarabine is a purine nucleoside antimetabolite marketed in the United States and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. It is FDA-approved for treating relapsed or refractory acute lymphoblastic leukaemia (ALL) in children after at least two other types of treatment have failed. Some investigations of effectiveness in cases of acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML) have been carried out. Ongoing trials are assessing its efficacy for managing other cancers.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Clolar, Evoltra |
AHFS/Drugs.com | Monograph |
MedlinePlus | a607012 |
License data |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.159.663 |
Chemical and physical data | |
Formula | C10H11ClFN5O3 |
Molar mass | 303.68 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close